Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | HTR7 | P34969 | 3/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.38 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | EDNRB | P24530 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10595614 | 0.81 | MCL1 (0.42) | MCL1HTR7TRPA1CTSDBACE1 | |
| SCHEMBL15638352 | 0.81 | MCL1 (0.42) | MCL1HTR7TRPA1CTSDBACE1 | |
| SCHEMBL8125021 | 0.81 | MCL1 (0.42) | MCL1HTR7TRPA1CTSDBACE1 | |
| SCHEMBL2015544 | 0.81 | PTPRC (0.43) | TRPA1BACE1PDK2NPC1RAB9A | |
| SCHEMBL15636889 | 0.81 | CYP2A6 (0.47) | TRPA1BACE1JAK3ARPDK2 | |
| SCHEMBL4429993 | 0.78 | S1PR4 (0.38) | BACE1CYP1A2ALDH1A1CASP3RAB9A | |
| SCHEMBL9545924 | 0.78 | HTR7 (0.41) | MCL1HTR7TRPA1CTSDBACE1 | |
| SCHEMBL4608554 | 0.78 | PTPRC (0.49) | HTR7CA12CA9ARPDK2 | |
| SCHEMBL3904470 | 0.78 | MCL1 (0.41) | MCL1HTR7TRPA1CTSDBACE1 | |
| SCHEMBL2254178 | 0.78 | MCL1 (0.45) | MCL1CA12CA9CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240122065-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | TOSOH CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4342883-A1 | PHOTOELECTRIC CONVERSION ELEMENT MATERIAL FOR IMAGING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT FOR IMAGING ELEMENT | Tosoh Corporation (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-117440940-A | Material for photoelectric conversion element for image pickup element and photoelectric conversion element for image pickup element | 东曹株式会社 | 2024-01-23 | — | — | CN | disclosed |
| CN-110997648-B | Condensed ring compound | 东曹株式会社 | 2023-12-19 | — | — | CN | disclosed |
| CN-117044428-A | Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element | 东曹株式会社 | 2023-11-10 | — | — | CN | disclosed |
| EP-4198163-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | Tosoh Corporation (JP) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023013615-A1 | AMINE COMPOUND, HOLE INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT | 東ソー株式会社 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023013697-A1 | MATERIAL FOR METAL PATTERNING, FLUORO COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENCE DEVICE, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | 東ソー株式会社 | 2023-02-09 | — | — | WO | disclosed |
| WO-2022260096-A1 | PHOTOELECTRIC CONVERSION ELEMENT MATERIAL FOR IMAGING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT FOR IMAGING ELEMENT | 東ソー株式会社 | 2022-12-15 | — | — | WO | disclosed |
| EP-3607002-A1 | COLORANT MIXTURES | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2020-02-12 | — | — | EP | disclosed |
| EP-1651614-B1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AG (DE) | 2007-07-11 | — | — | EP | disclosed |
| EP-1740171-A1 | INDOL-1-YL-ACETIC ACID DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2007-01-10 | — | — | EP | disclosed |
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-06 | — | — | US | disclosed |
| US-7053244-B2 | Method for the continuous production of tetra-substituted ureas | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-30 | — | — | US | disclosed |
| EP-1651614-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-03 | — | — | EP | disclosed |
| US-20050261524-A1 | Method for the continuous production of tetra-substituted ureas | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-24 | — | — | US | disclosed |
| WO-2005094816-A1 | INDOL-1-YL-ACETIC ACID DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005019183-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| EP-1028945-A1 | SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | Amgen Inc. (US) | 2000-08-23 | — | — | EP | disclosed |
| WO-1999024404-A1 | SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | AMGEN INC. (US) | 1999-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | HIRA, HAO2, HACL2 | MCL1 3066/4885HTR7 1005/4885TRPA1 1077/4885 |
| US-20050261524-A1 | Method for the continuous production of tetra-substituted ureas | UGP2, UTS2R, UMPS | MCL1 4183/4885HTR7 1803/4885TRPA1 3162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.